Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Ophthalmic Drug

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1733499

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1733499

Dry Eye Disease

PUBLISHED:
PAGES: 390 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Dry Eye Disease Market to Reach US$11.0 Billion by 2030

The global market for Dry Eye Disease estimated at US$7.1 Billion in the year 2024, is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Cyclosporine, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Corticosteroids segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 11.4% CAGR

The Dry Eye Disease market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Dry Eye Disease Market - Key Trends & Drivers Summarized

What Is Fueling the Surge in Dry Eye Disease Cases Worldwide?

Dry Eye Disease (DED), medically referred to as keratoconjunctivitis sicca, is witnessing a significant global rise in prevalence due to multiple converging lifestyle, demographic, and environmental factors. This chronic ocular condition is caused by either inadequate tear production or excessive evaporation, resulting in inflammation, ocular surface damage, and persistent discomfort. Populations over the age of 50 are particularly susceptible, making aging one of the most critical contributors to the growing incidence of DED. However, younger demographics are not exempt, especially given the ubiquity of digital screens. Extended screen exposure significantly reduces blink rate and tear film stability, leading to tear evaporation and dry eye symptoms.

Urbanization and pollution are also contributing to this surge. Particulate matter, low humidity environments, and exposure to air conditioning are proven aggravators of ocular dryness. In addition, the widespread use of contact lenses, refractive surgeries like LASIK, and systemic medications such as antihistamines and antidepressants are known to exacerbate or trigger dry eye conditions. The disease affects daily tasks such as reading, driving, or prolonged visual focus, reducing quality of life and productivity. With awareness rising among both patients and healthcare providers, the rate of diagnosis is increasing, intensifying the demand for effective and accessible therapeutic solutions.

Which Innovations Are Transforming Dry Eye Disease Management?

The treatment landscape for Dry Eye Disease is undergoing rapid transformation, driven by advances in both diagnostics and therapeutic interventions. Diagnostic techniques have evolved far beyond traditional Schirmer tests, with clinicians now utilizing tear osmolarity testing, non-invasive tear break-up time analysis, and meibography to assess meibomian gland dysfunction, a leading cause of evaporative dry eye. These innovations enable precise subtyping of the disease, allowing clinicians to adopt a more targeted approach to therapy. Digital imaging tools and point-of-care analyzers are making diagnostics more accurate, faster, and accessible in both hospital and outpatient settings.

Pharmacological advancements have also redefined treatment protocols. Anti-inflammatory eye drops such as cyclosporine A and lifitegrast have emerged as frontline agents in managing chronic dry eye associated with inflammation. These drugs offer more sustained relief than artificial tears, which, although still widely used, only provide temporary symptomatic relief. Further innovation is seen in the rise of sustained-release drug delivery systems-such as drug-eluting punctal plugs and inserts-which improve therapeutic adherence and patient outcomes. Additionally, non-drug therapies like intense pulsed light (IPL) treatment, thermal pulsation devices, and in-office gland expression procedures are helping restore ocular surface health in patients with moderate to severe disease.

How Are Diverse Sectors Addressing the Challenges of Dry Eye Disease?

The rising burden of Dry Eye Disease is prompting multifaceted responses across healthcare systems, pharmaceutical companies, and even corporate employers. In the healthcare setting, early diagnosis and personalized management strategies are being emphasized. Ophthalmologists and optometrists are incorporating comprehensive ocular surface evaluations into routine checkups, recognizing the long-term implications of untreated DED. The integration of digital health platforms is also expanding access to care, with teleophthalmology services providing remote assessments, especially in underserved and rural regions. These platforms are helping monitor disease progression, reinforce medication adherence, and educate patients on environmental and behavioral modifications.

Pharmaceutical companies are aggressively investing in the development of novel compounds, combination therapies, and biologics tailored for specific subtypes of dry eye. There is a notable shift from one-size-fits-all solutions to therapies based on individual disease etiology, such as aqueous-deficient versus evaporative dry eye. At the same time, industry collaborations between biotech firms and academic research institutions are accelerating discovery pipelines through the use of ocular surface biomarkers, artificial intelligence, and big data analytics. In the corporate sector, awareness of the impact of DED on employee well-being and productivity has led to workplace interventions, such as screen time management, improved ergonomics, and indoor air quality enhancements. These cross-sector initiatives reflect a growing recognition of dry eye as not just a medical condition, but a broader public health and quality-of-life issue.

What Is Driving Market Growth and Strategic Investment in Dry Eye Disease Solutions?

The growth in the dry eye disease market is driven by several factors related to technological innovation, rising prevalence, and evolving treatment paradigms. One of the primary drivers is the global demographic shift toward an aging population, which corresponds with increased susceptibility to tear dysfunction and ocular surface damage. Equally influential is the surge in digital device usage across all age groups, as prolonged screen exposure continues to undermine blink frequency and tear film integrity, especially in urban and professional environments. These behavioral shifts are expanding the DED patient pool far beyond traditional risk categories.

On the technological front, sustained progress in drug delivery systems and diagnostics is accelerating treatment adoption and improving patient outcomes. The regulatory landscape is also becoming more conducive, with expedited approval pathways for novel ophthalmic drugs encouraging innovation and investment. In parallel, there is increasing awareness and screening activity driven by public health campaigns, eye health initiatives, and improved insurance coverage for specialty eye care. As dry eye gains recognition as a chronic and often progressive disease, healthcare stakeholders are allocating greater resources to research, product development, and patient education. These factors are collectively propelling the global dry eye disease market forward, setting the stage for sustained growth and diversification in both prescription and non-prescription segments over the next decade.

SCOPE OF STUDY:

The report analyzes the Dry Eye Disease market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs, Other Product Types); Formulation Type (Liquid, Gel, Ointment, Other Formulation Types); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 39 Featured) -

  • AbbVie Inc.
  • Akorn Operating Company LLC
  • Alcon Inc.
  • Aldeyra Therapeutics, Inc.
  • Allergan plc (AbbVie)
  • Bausch + Lomb Incorporated
  • Horus Pharma
  • Johnson & Johnson
  • Mitotech S.A.
  • Nicox S.A.
  • Novaliq GmbH
  • Novartis AG
  • OASIS Medical
  • OKYO Pharma Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Rohto Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Schwind eye-tech-solutions GmbH
  • Sentiss Pharma Pvt. Ltd.
  • Surface Ophthalmics, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP33755

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Dry Eye Disease - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Population and Screen Overuse Trends Propel Growth of Dry Eye Therapeutics Market
    • Advancements in Tear Film Imaging and Diagnosis Accelerate Early Detection and Intervention
    • Increased Use of Digital Devices Strengthens Business Case for Preventive Dry Eye Treatments
    • Rising Adoption of Combination Therapy Approaches Enhances Treatment Outcomes
    • Introduction of Targeted Biologics Drives Innovation in Chronic Dry Eye Management
    • OTC Lubricant and Drop Market Expansion Sustains High Volumes in Mild Dry Eye Segments
    • Advances in Meibomian Gland Dysfunction Therapies Expand Treatment Options for Severe Cases
    • Rise in LASIK and Refractive Surgery Complications Drives Post-Procedure Dry Eye Treatment Demand
    • AI-Powered Ocular Surface Assessment Tools Improve Diagnostic Accuracy and Personalization
    • Global Increase in Contact Lens Usage Highlights Preventive Role of Lubricants and Moisturizers
    • Telemedicine Platforms Expand Access to Eye Care, Enhancing Dry Eye Diagnosis in Underserved Areas
    • Growing Consumer Interest in Natural and Preservative-Free Formulations Creates Niche Opportunities
    • Environmental Pollution and Indoor Air Quality Concerns Contribute to Global Disease Burden
    • Increased Investment in Ocular Inflammation Research Promotes Drug Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Dry Eye Disease Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Dry Eye Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Dry Eye Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Dry Eye Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cyclosporine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cyclosporine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cyclosporine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Corticosteroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Corticosteroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Lifitegrast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Lifitegrast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Lifitegrast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ocular Lubricant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ocular Lubricant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ocular Lubricant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Punctal Plugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Punctal Plugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Punctal Plugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Formulation Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Formulation Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Formulation Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ointment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ointment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Ointment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Supermarkets / Hypermarkets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Supermarkets / Hypermarkets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Stores by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • JAPAN
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • CHINA
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • EUROPE
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Dry Eye Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Dry Eye Disease by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Dry Eye Disease by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • FRANCE
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • GERMANY
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 140: Spain Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Spain Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Spain 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 149: Russia Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Russia Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Russia 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Dry Eye Disease by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Dry Eye Disease by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 179: Australia Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Australia Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Australia 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • INDIA
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 182: India Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 188: India Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: India Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: India 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 197: South Korea Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: South Korea Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: South Korea 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Asia-Pacific Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Dry Eye Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Dry Eye Disease by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Dry Eye Disease by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 218: Latin America Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Latin America Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Latin America 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 227: Argentina Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Argentina Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Argentina 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 236: Brazil Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Brazil Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Brazil 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 245: Mexico Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Mexico Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Mexico 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Latin America Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Latin America 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Dry Eye Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Dry Eye Disease by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Dry Eye Disease by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 266: Middle East Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Middle East Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Middle East 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 275: Iran Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Iran Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Iran 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 284: Israel Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Israel Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Israel 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Saudi Arabia Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Saudi Arabia 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 302: UAE Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: UAE Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: UAE 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Middle East Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Middle East 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030
  • AFRICA
    • Dry Eye Disease Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Dry Eye Disease by Product Type - Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Dry Eye Disease by Product Type - Percentage Breakdown of Value Sales for Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Dry Eye Disease by Formulation Type - Other Formulation Types, Liquid, Gel and Ointment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Dry Eye Disease by Formulation Type - Percentage Breakdown of Value Sales for Other Formulation Types, Liquid, Gel and Ointment for the Years 2015, 2025 & 2030
    • TABLE 320: Africa Recent Past, Current & Future Analysis for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Africa Historic Review for Dry Eye Disease by Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Africa 15-Year Perspective for Dry Eye Disease by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies, Supermarkets / Hypermarkets, Other Stores and Online Pharmacies for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!